There is more than Mozart, Sissi and Sacher cake! The pragmatic reimbursement pathways in Austria?!

Austria is in the center of Europe and has a high quality health care system. Recently there have been major changes within the insurance system which might also have longer term impact on reimbursement. Currently reimbursement pathways are seen as more pragmatic in comparison to other countries – not only in the inpatient setting. Listen and learn from the Austrian experts Dr. Stefan Walzer and Dr. Thorsten Peske.

Register now!

MArS goes Clubhouse (again) – 10 years AMNOG

After a great webinar on “10 years AMNOG” on Thursday evening, we are happy to announce that the discussions are expanded into the German-speaking community! MArS Market Access & Pricing Strategy GmbH goes (again) to Clubhouse!! The session on April 1 2021 will be recorded and made available afterwards as well – but even better, join us and discuss directly with well-known experts: Dr. Stefan Walzer, Prof. Dr. David Matusiewicz, Bibiane Schulte-Bosse, Dr. Mathias Flume, Heiko Schellhorn, Prof. Dr. Thomas Hammerschmidt – moderation as always by Lutz Vollmer!!

Join us at Clubhouse!!

10 years AMNOG – what have we learnt for drug development and pricing?

10 years ago, the German reimbursement system for drugs changed significantly. The AMNOG including a benefit assessment and price negotiation was launched. Threats were seen, but also opportunities – the AMNOG frame was criticized and in some aspects also changed over time. A learning system – as some say.
The speakers have worked and shaped the AMNOG process also before its implementation and have also been working since the start of it in various roles and on different products. The presentation and discussions will shows the following key aspects:

  • What are key success factors for a optimal AMNOG process?
  • Are there any guidances for clinical development?
  • How is the benefit rating and price negotiation correlated? What are drivers?
  • What can we expect in the future from the AMNOG?

Register now!

The end of Covid-19 due to vaccines? By when do we have our lives back?

The covid-19 outbreak has had a significant impact on daily life of populations in the last year. Recently three pharmaceutical companies have communicated promising results of their vaccination candidates against Covid-19. Various countries in Europe have implemented vaccination programs or strategies how to set these up. Within the webinar those programs will be assessed utilizing a Covid-19 SEIR model (CovidSIM). The MArS expert team will show you in the webinar:
• Vaccination programs in Europe
• Implication of these programs from a simulation perspective
• An estimation of when the “old” normal might be the “new(set)” normal

The webinar will be held one week before Christmas. The first 24 registrations will receive a German “Gluehwein” as normally available on German Christmas markets.

The potential impact of the 2020 US presidential election on global health care pricing

The expert teams of MArS and PSE will summarize the results of the US presidential election before detailed discussions and finding on the potential health care changes and its global impact will be discussed. Most likely the potential price referencing of US prices to a global country basket will be included as other specific items.

Register now for the free webinar on November 24 2020at 9pm CET / noon PT: Register

Innovative price contracting in the German AMNOG process – is this the future or just a dream?

The presenters Dr. Stefan Walzer and Roman Spelsberg analyzed the current situation of the AMNOG process with respect to price contracting. They will show opportunities and hurdles of the current system as well as current examples. Furthermore, they will also come up with a suggestion how innovative contracting could be implemented in Germany – even further…

 

Register now for our new free webinar! https://us02web.zoom.us/webinar/register/3016007018391/WN_jAWzjHTbSK2m2fUXJoqLtg

Market Access & reimbursement for digital health applications

In Germany, a new market access and reimbursement process for digital health applications (DiGAs) was introduced in early 2020. In our approx. 45-minute webinar, you will learn what this new process looks like and which similar processes may exist in a European comparison. The French expert Guy Eiferman from the Market Access consulting agency Nextep will speak about the French process. The webinar will conclude with a panel discussion on the main differences and similarities between France and Germany as driving forces for digital innovation in Europe.

Register now!!

Start-up failures – How can you plan for a successful market launch?

In a recent study funded by the Dutch government it was found that roughly 91% of start-ups fail! What are the reasons for that and more important how could you plan to be successful? MArS in cooperation with the Dutch consultancy Seijgraaf will present and discuss findings and solutions for a successful market access of health care start-ups. The webinar will include the following topics: • What are the major issues health care start-ups have when preparing to enter the launch? • What are must-haves in terms of market access and reimbursement for new products in the health care system? • How can a health care start-up be successful?

New Webinar on Covid-19 and digitalization on May 28 2020

The covid-19 outbreak has had a significant impact on daily life of populations and health care systems. Due to physical distancing as a core policy, digitalization is a main opportunity also in health care. At the same time the new law for digitalization in health care (DiGA) was made effective In Germany.

The MArS Covid-19 task force will show you in this webinar:

  • How digitalization has changed the health care system
  • The different pathways for digitalization solutions to the German market

Register now: Webinars

Covid-19 crisis makes KOLs availability difficult – MArS has the solution

Given the covid-19 crisis, most clinical KOLs are no more able to attend any physical meetings or even phone calls due to the heavy work load in some areas of the D-A-CH countries!
MArS is working since years in a step-wise approach for such situations, when KOLs might be difficult to be approached:
  • Physical Advisory Board Meeting
  • Virtual Advisory Board Meeting
  • Virtual Delphi Panel

Please contact us directly and get your tailor-made solution to stay in contact with your KOLs: stefan.walzer@marketaccess-pricingstrategy.de